First-line biological versus conventional synthetic disease-modifying antirheumatic drug therapy in adult-onset Still's disease: a multicentre, retrospective, propensity weighted cohort study +++

https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(25)00023-2/fulltext?dgcid=raven_jbs_etoc_feature_lanrhe IgG4-related disease: the future is promising The Lancet Rheumatology https://www.thelancet.com/journals/lanrhe/issue/vol7no6/PIIS2665-9913(25)X0006-0 Dominique Farge on allogeneic umbilical cord-derived mesenchymal stromal cells for systemic lupus erythematosus The Lancet Rheumatology in conversation with https://www.thelancet.com/multimedia/podcasts/in-conversation-with/lanrhe?dgcid=raven_jbs_etoc_feature_lanrhe